Academic literature on the topic 'And Pushkarmool (Inula racemosa) etc'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'And Pushkarmool (Inula racemosa) etc.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "And Pushkarmool (Inula racemosa) etc"

1

Aakash, Chaudhari* Dr. Chandrakant Suryawanshi. Dr. Rajendra Waugh. "RP-HPLC Method for Simultaneous Quantification of Arjuna, Ashwagandha, and Pushkarmool in Marketed Herbal Cardioprotective Tablets (Dabur: Arjuna Tablet)." International Journal of Pharmaceutical Sciences 3, no. 3 (2025): 3353–66. https://doi.org/10.5281/zenodo.15112888.

Full text
Abstract:
The present study aimed to develop and optimize a robust RP-HPLC method for the simultaneous quantification of Arjuna (<em>Terminalia Arjuna</em>), Ashwagandha (<em>Withania somnifera</em>), and Pushkarmool (<em>Inula racemosa</em>) in Dabur: Arjuna Tablet, a marketed herbal Cardioprotective formulation. The identity of the formulation was confirmed using UV-Visible spectroscopy and FT-IR analysis. Chromatographic conditions were optimized using different mobile phase compositions, with the selected method (Acetonitrile: Methanol: Glacial Acetic Acid, 60:30:10 v/v/v) providing well-resolved peaks, high sensitivity, and reproducibility at 285 nm.&nbsp; The method was validated for specificity, linearity, precision, accuracy, robustness, and system suitability. It exhibited excellent linearity (R&sup2; &gt; 0.99), low LOD (0.312 &mu;g/ml) and LOQ (1.025 &mu;g/ml), and high precision (%RSD &lt; 2%). Recovery studies confirmed accuracy (97.89&ndash;98.89%), while robustness testing demonstrated method stability under minor variations. The formulation assay showed consistent retention times (2.2&ndash;5.8 min) and high recovery (&gt;84%).&nbsp; Forced degradation studies under acidic, alkaline, oxidative, thermal, and photolytic conditions confirmed the stability-indicating nature of the method. The formulation was sensitive to oxidation and light exposure, while thermal stress caused minimal degradation. The developed RP-HPLC method successfully quantified bioactive compounds in Dabur: Arjuna Tablet, ensuring its therapeutic efficacy and stability. It is suitable for routine quality control and standardization of herbal Cardioprotective formulations.
APA, Harvard, Vancouver, ISO, and other styles
2

Sharma, Rajender Kumar, Bela Bhatia, Anju K. Chhibbar, et al. "Substitute of Light Requirement for Germination in Positive Photoblastic Seeds of Inula racemosa - A Critically Endangered Medicinal and Aromatic Plant of North-Western Himalaya, India." International Journal of Ecology and Environmental Sciences 50, no. 3 (2024): 377–83. http://dx.doi.org/10.55863/ijees.2024.0015.

Full text
Abstract:
Inula racemosa, commonly known as pushkarmool, has high economic value due to its medicinal and aromatic properties. The species has been over-exploited for commercial purposes and become threatened (critically endangered) in NW Himalaya. The seeds exhibited photo-sensitivity and were complete positive photoblastic. They germinated (80%) only when exposed to light; no germination was recorded in dark. The hydrated seeds required only a brief exposure of light to initiate germination, thus can be categorized under Low-Fluence Responces (LFRs). Under natural field conditions the seeds do not germinated when sown below 1.5 cm soil depth, as the light became limiting factor. Interestingly, GA3 (1 mM) substituted the requirement of light for germination; 70% germination was recorded under complete darkness due to GA3. These observations are completely new for seeds of I. racemosa and discussed in detail. The findings have practical applications for seed-based multiplication of the species.
APA, Harvard, Vancouver, ISO, and other styles
3

R., Kaur, Kashyap Aditi, Majeed Sadiq, and S. Chauhan N. "In vitro Propagation and Conservation of Inula racemosa Hook. F. an Endangered Medicinal Plant of Temperate Origin." Journal of Advanced Laboratory Research in Biology 1, no. 1 (2010): 67–70. https://doi.org/10.5281/zenodo.1317780.

Full text
Abstract:
<em>Inula racemosa</em>&nbsp;is an endangered medicinal plant. It is commonly known as Pushkarmool, Pushkar and Manu. The great sage Charaka has characterized it as&nbsp;<em>Hikka magrahana</em>&nbsp;(stops hiccups) and&nbsp;<em>Savasahara</em>(helpful in asthma). Also, he has cited it as the best medicament for pleurisy along with cough and asthma (http://enwikipedia.org/wiki/charaka-samhita). Due to the fragile nature of its habitat and exploitation due to its commercial medicinal properties, the species are facing the onslaught of indiscriminate over-exploitation. So far, this plant has not got the required attention from researchers, hence, except for a few efforts, not much work has been done for its cultivation and conservation. Plant tissue culture offers an attractive and quick method for its multiplication and further conservation. In the present investigation, effective procedures for micropropagation and&nbsp;<em>in vitro</em>conservation by vitrification were developed. In vitro propagation using aseptically grown seedlings and in vitro conservation via vitrification were standardized. The&nbsp;<em>in vitro</em>&nbsp;conserved material could be retrieved and multiplied normally on MS (Murashige and Skoog, 1962) medium fortified with 1.00 mg l-1BA (benzyl adenine) which has been recorded as the best performing medium for in vitro shoot multiplication. The conserved shoots showed normal in vitro propagation and after retrieval from vitrification, platelets were hardened and successfully established in the experimental fields under Nauni (Solan, HP) conditions at an elevation of around 1275 meters above mean sea level.
APA, Harvard, Vancouver, ISO, and other styles
4

Nagar, Lalit, Ringzin Lamo, and Sudipt Kumar Rath. "50% H2SO4 TEST: A SIMPLE TEST TO DIFFERENTIATE BETWEEN PUSHKARMOOL (Inula racemosa Hook.f.) AND KUSTHA (Saussurea lappa C. B. Clarke)." International Journal of Research in Ayurveda & Pharmacy 8, no. 5 (2017): 46–48. http://dx.doi.org/10.7897/2277-4343.085241.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Yousuf, Aamir, Suheena Khanday, Sajad Salim, and Afsahul Kalam. "PHARMACOGNOSTICAL, PHYSICOCHEMICAL AND PHYTOCHEMICAL EVALUATION OF RASAN ROOT INULA RACEMOSA HOOK. F. (ASTERACEACE): AN ENDANGERED MEDICINAL PLANT OF KASHMIR." INDIAN JOURNAL OF UNANI MEDICINE 15, no. 01 (2022): 01–12. http://dx.doi.org/10.53390/ijum.2022.15101.

Full text
Abstract:
Inula racemosa Hook. F. commonly known as “rasan” is a stout perennial herb which belongs to family Asteraceace with peculiar and limited distribution from temperate to alpine belts of Kashmir and Himachal Pradesh. In Kashmir, Rasan is found inadequately in the areas of Gurez (1586 m), Farozpora (2150 m), Gulmarg (2650 m), Simthantop (3784 m), Razdantop (3300 m) and KUBG (1595 m). The locals have been applying the paste of root mixed with some edible oils to treat scabies and chest pain. Traditionally the roots are used for treatment of phlegmatic migraine, melancholia, severe flatulence, loss of appetite, intestinal worms liver diseases, obstructive and non-obstructive jaundice, chronic bronchitis, bronchial asthma, diabetes mellitus, leprosy, paralysis, amenorrhea, dysmenorrhea, urinary incontinence. etc (Galen) (Baitar, 1999) (Ghani, 2010) (Magrabi, 2007).. Since there is no detailed standardization work done on the above plant, Therefore, it has been analyzed through pharmacognostic techniques such as morphological, microscopic, and physio-chemical evaluations to keep the originality of the plant and to avoid adulteration. Preliminary phytochemical screening confirmed the presence of gylcosides, tannins, sterols, terpenoids, coumarins, saponins, proteins, phenols, saponins. The above-mentioned studies that have been reported, for the first time, for the said plant may be significant to establish the pharmacognostic and phytochemical standards of the said species.
APA, Harvard, Vancouver, ISO, and other styles
6

Baile, Sunil Bhaurao, and Ghanshyam Ratilal Parmar. "A Comprehensive Review on the Ethnopharmacological Potential of <i>Inula racemosa</i>." Journal of Natural Remedies, December 5, 2024, 2381–95. https://doi.org/10.18311/jnr/2024/44842.

Full text
Abstract:
Inula racemosa, Pushkarmool or Indian elecampane, is a perennial herbaceous plant indigenous to the Himalayan region and various parts of Central Asia. It is classified within the Asteraceae family and is characterised by its tall stature, prominent foliage, and clusters of yellow blossoms. It has traditionally been a staple in Ayurvedic medicine due to its multifaceted therapeutic attributes, including expectorant, diuretic, and anti-inflammatory properties. Through chemical analysis, key bioactive constituents such as alantolactone and isoalantolactone have been identified, underscoring their medicinal significance. Emerging research underscores the potential of I. racemosa extracts in addressing respiratory disorders, gastrointestinal maladies, and inflammatory ailments. Nevertheless, comprehensive investigations are imperative to delineate its pharmacological mechanisms and potential adverse reactions.
APA, Harvard, Vancouver, ISO, and other styles
7

Rana, C. S., Y. S. Negi, L. P. Sawant, and Pankaj Prasad Raturi. "Commercial Cultivation and Sustainability of Pushkarmool (Inula racemosa), A Case Study from Keylong, Lauhal & Spiti, Himachal Pradesh, India." Journal of Mountain Research 17, no. 2 (2022). http://dx.doi.org/10.51220/jmr.v17i2.3.

Full text
Abstract:
In the recent years demand of the medicinal and aromatic plants has grown rapidly because of accelerated national and international industrial interest on herbal and Ayurvedic products. Due to this increasing consumption and continued unsustainable collection from the wild habitats and dwindling cultivation practices, numerous high altitude medicinal plants are now on verge of extinction from the wild sources. Variable price status, production limitations, biodiversity rules &amp;regulations and lack of trust among supply chain are preventing producers from taking up continued cultivation practices. Inula racemosa Hk.f. is one of them which belong to family Asteraceae locally known as Manuand traded as Pushkarmool. It is a rare perennial alpine herb having restricted wild habitats in India. Pushkarmool is widely used in traditional codified and non-codified medicines in India and Tibet.The species take two to three years for producing its yields as root parts for the Ayurvedic medicine and there is no sustainable way, harvesting practices for the conservation of this species. The present study explained steps followed by the private and public partnership. It is a case study which was started in the years 2007-08 by the LMS (Lahaul Medicinal Plant Society) and Dabur India Limited has jointly put the joint efforts to bring Pushkarmool under commercial cultivation. The LMS had played a key role in coordinating and mobilizing the self-help groups (SHGs), government and non-government organization and other institutions in the district Lahaul &amp; Spiti to help privileged local farmers to link up with reliable markets of the raw material with a tie up with Dabur India Ltd, New Delhi. We can promote the cultivation of such medicinal plants by involving the local farmers and bringing these under cultivation which not only helps the conservation of the species, but this has also helped to provide the extra income to the local and native farmers and play a critical role in enhancing their livelihood. The study may be considered as test case for successful conservation by bringing species domestication for the commercial cultivation.
APA, Harvard, Vancouver, ISO, and other styles
8

Kumar, Ajay, Rahul Dev Gautam, Romika Thakur, et al. "STABILITY STUDIES FOR HIGHER ROOT BIOMASS AND ESSENTIAL OIL CONTENT IN INULA RACEMOSA HOOK. F. PUSHKARMOOL SELECTIONS UNDER WESTERN HIMALAYAN CONDITIONS." Plant Archives 24, no. 2 (2024). https://doi.org/10.51470/plantarchives.2024.v24.no.2.001.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Saurabha Nayak, Bipin Bihari Khuntia, and Durga Prasad. "Evaluation of Antihyperlipidaemic and Cardioprotective Action of a Herbal Formulation." AYUSHDHARA, March 7, 2024, 1–7. http://dx.doi.org/10.47070/ayushdhara.v11i1.1494.

Full text
Abstract:
As per WHO, Cardiovascular diseases (CVDs) are the leading cause of death globally. CVDs also impart a huge financial burden and remain a hurdle for sustainable development in low and middle income countries. Hence there is an urgent need to identify individuals with high CVD risk and begin appropriate preventive intervention well in advance. In this study, 60 individuals of either sex, within the age group of 30 – 70 years, having hyperlipidaemia along with more than 10% of CVD risk were identified in lipid screening camps with the help of JBS 3 Heart Risk android application tool. A combination of three well known herbs in capsule form containing 500mg extract of Guggulu (Commiphora mukul), Pushkarmool (Inula racemosa) and Arjuna (Terminalia arjuna) in equal proportion was administered in a dose of 1 capsule twice daily after food with warm water for 3 months to treat hyperlipidaemia. Only 55 participants completed the trial. Different parameters of lipid profile, CVD risk score and biological heart age were compared before and after treatment using appropriate statistical method. The intervention resulted in reduction of total cholesterol by 17.49%, LDL by 21.04%, VLDL by 24.55% and Triglycerides by 24.55% whereas HDL increased by 10.48 %. As a secondary outcome, the mean CVD risk score was reduced by 6.91% and the mean biological heart age was also reduced by 6.64 years. The trial drug was well tolerated and free from adverse effects. Hence the trial drug can offer a safe and effective solution to individuals with hyperlipidaemia and moderate CVD risk.
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "And Pushkarmool (Inula racemosa) etc"

1

Wangchuk, Phurpa, and Tenzin Jamtsho. "Inula racemosa Hook. f. Pushkarmool: Its Ethnobotanical Uses, Phytochemicals, and Pharmacological Activities." In Immunity Boosting Medicinal Plants of the Western Himalayas. Springer Nature Singapore, 2023. http://dx.doi.org/10.1007/978-981-19-9501-9_11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Thakur, Romika, Diksha Dhiman, Sanatsujat Singh, and Ramesh Chauhan. "Distribution, Challenges, and Conservation of an Industrially Important Medicinal Plant, Pushkarmool (Inula racemosa Hook. f.)." In Ethnopharmacology and OMICS Advances in Medicinal Plants Volume 2. Springer Nature Singapore, 2024. http://dx.doi.org/10.1007/978-981-97-4292-9_6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography